Previous Close | 26.66 |
1-Year Change | -24.39% |
6-Months Change | -37.56% |
3-Months Change | -30.37% |
Moving Avg (50d) | 31.293 |
Moving Avg (200d) | 37.596 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 1.3B |
Beta (3-Years) | 1.7 |
Revenue Growth (ttm) | 11.04% |
Net Profit Margin (ttm) | 6.56% |
Return On Assets (ttm) | 4.32% |
EPS (ttm) | 0.4 |
PE Ratio (ttm) | 66.65 |
Dividend Yield | % |
Asset Description: | STAAR Surgical Company |
Predicted Direction: | Sell |
Signal Strength: | Strong sell |
Forecast Date: | 2024-09-23 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
26.846 | 27.636 | 28.162 | 28.952 | 30.268 | 31.584 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Health Care Supplies |
Country: | United States |